Saturday, October 31, 2026

Women in Business Isn't Anything New, It's Been Happening for 20 Years, Says Isabel Neves of Portuguese Shark Tank

Isabel Neves, president of Lisbon Business Angels Club and Shark Tank Portugal investor, discussed women in business and entrepreneurship. "Shark Tank is a great moment for me because I can show what I do, what I love."

LM Salvado
LM Salvado

February 4, 2017

Isabel Neves Interview - Lisbon Business Angels Club President
Isabel Neves is the president of the Lisbon Business Angels Club (LBAC) and one of the investors in Shark Tank Portugal. We met with her for an interview during the third anniversary of the LBAC, in which another round of startup pitches took place. It was a full house event where angel investors and startups got the chance to meet each other to handle business opportunities. In this interview, Isabel Neves talks about the kind of business she's looking for, the traits of a successful entrepreneur, and the growing participation of women in business. Miguel Salvado: Isabel Neves, Welcome. Isabel Neves: Thank you very much.
"Shark Tank is a great moment for me because I can show what I do, what I love, and I've been finding very good projects"

Isabel Neves

Tell us about your experience with Shark Tank Portugal. It's a great experience. I think it's a great moment for me because I can show what I do, what I love, and I've been finding very good projects. What kind of projects are you looking for? Very different. Projects in the cosmetic, cork, fashion, and education industries. These are four different areas and projects, for different and lovely persons.
"In a pitch, you must show three things: what you do, what you do different from others, and which is your market."

Isabel Neves

What everybody wants to know is when you listen to a startup pitch, what kind of indicators do you feel to be the right ones for you to invest? In a pitch, you must show three things: what you do, what you do differently from others, and which is your market. These three different things are very important to me when listening to a pitch. Another thing which is very important to me is the determination of the entrepreneur. [caption id="attachment_1476" align="aligncenter" width="640"]Isabel Neves Interview - Lisbon Business Angels Club President Isabel Neves Interview - Lisbon Business Angels Club President[/caption]
"The entrepreneur must be a mentally strong person, very determined and resilient."

Isabel Neves

For you as an investor, what kind of traits do you find interesting in an entrepreneur? The entrepreneur must be a mentally strong person, very determined and resilient, that's very important.
"Women are everywhere, in schools, in universities, in politics. It's not really a phenomenon of our days because it has been happening over the last 20 years."

Isabel Neves

Just last week at the Web Summit, the CEO Paddy Cosgrave said there was a record for women attendees. How do you feel about the growing participation of women in business? Everybody talks about the growing participation of women in business, I've been witnessing this situation from 20 years ago, so I saw this phenomenon unfolding first-hand. This is not something that happens only today. If people saw the mutation in this world during the last two decades, women are everywhere, in schools, in universities, in politics so it's not really a phenomenon of our days but has been happening over the last 20 years. If you could sum up in a sentence a good piece of advice to share with young entrepreneurs, what would you say? Go, fly away, because the world is ours. Isabel Neves, thank you very much for this interview. Thank you very much.
LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com